Cited by 303Diabetes Management and ResearchDiabetic Foot Ulcer Assessment and ManagementPeripheral Neuropathies and Disorders

Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for Diabetes in Youth study

Open access
Jaiswal, Mamta, Divers, Jasmin, Dabelea, Dana, Isom, Scott, Bell, Ronny A., Martin, Catherine L., Pettitt, David J., Saydah, Sharon +8 more·2017·Diabetes Care

Abstract

OBJECTIVE: We assessed the prevalence of and risk factors for diabetic peripheral neuropathy (DPN) in youth with type 1 diabetes (T1D) and type 2 diabetes (T2D) enrolled in the SEARCH for Diabetes in Youth (SEARCH) study. RESEARCH DESIGN AND METHODS: The Michigan Neuropathy Screening Instrument (MNSI) was used to assess DPN in 1,734 youth with T1D (mean ± SD age 18 ± 4 years, T1D duration 7.2 ± 1.2 years, and HbA1c 9.1 ± 1.9%) and 258 youth with T2D (age 22 ± 3.5 years, T2D duration 7.9 ± 2 years, and HbA1c 9.4 ± 2.3%) who were enrolled in the SEARCH study and had ≥5 years of diabetes duration. DPN was defined as an MNSI exam score of >2. Glycemic control over time was estimated as area under the curve for HbA1c. RESULTS: The prevalence of DPN was 7% in youth with T1D and 22% in youth with T2D. Risk factors for DPN in youth with T1D were older age, longer diabetes duration, smoking, increased diastolic blood pressure, obesity, increased LDL cholesterol and triglycerides, and lower HDL cholesterol (HDL-c). In youth with T2D, risk factors were older age, male sex, longer diabetes duration, smoking, and lower HDL-c. Glycemic control over time was worse among those with DPN compared with those without for youth with T1D (odds ratio 1.53 [95% CI 1.24; 1.88]) but not for youth with T2D (1.05 [0.7; 1.56]). CONCLUSIONS: The high rates of DPN among youth with diabetes are a cause of concern and suggest a need for early screening and better risk factor management. Interventions in youth that address poor glycemic control and dyslipidemia may prevent or delay debilitating neuropathic complications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc17-0179

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Risk factors for the development and progression of diabetic neuropathy include poor glycemic control, duration of diabetes, hypertension, lipid abnormalities, smoking cessation, and obesity.

    “Risk factors for the development and progression of diabetic neuropathy include poor glycemic control, duration of diabetes, hypertension, lipid abnormalities, smoking cessation, and obesity.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jaiswal, M., Divers, J., Dabelea, D., Isom, S., Bell, R. A., Martin, C. L., Pettitt, D. J., Saydah, S., Pihoker, C., Standiford, D. A., Dolan, L. M., Marcovina, S., Linder, B., Liese, A. D., Pop-Busui, R., & Feldman, E. L.
Affiliations
  • University of Michigan (US)
  • Wake Forest University Health Sciences (US)
  • Colorado School of Public Health (US)
  • Santa Barbara, CA
  • Centers for Disease Control and Prevention (US)
  • University of Washington (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • National Institutes of Health (US)
  • University of South Carolina (US)
  • Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI
Corresponding author
Feldman, Eva L.
Venue
Diabetes Care
Published
2017-07-03
Volume
40
Issue
9
Pages
1226-1232
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2726668995
Cited by
303
References
32
Citations by year
2026: 14 · 2025: 29 · 2024: 36 · 2023: 42 · 2022: 44 · 2021: 38 · 2020: 48 · 2019: 28 · 2018: 22 · 2017: 2
FWCI
21.63
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute for Health Research (1UC4DK108173-01)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
  • Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
Keywords
diabetic peripheral neuropathy, youth with diabetes, type 1 diabetes, type 2 diabetes, prevalence, risk factors, glycemic control, HbA1c, dyslipidemia, HDL cholesterol, smoking, diabetes duration, Michigan Neuropathy Screening Instrument, SEARCH for Diabetes in Youth
MeSH terms
Adolescent, Adult, Blood Glucose, Blood Pressure, Cholesterol, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Body Mass Index, Prevalence, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review